Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Current Leases (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Current Leases for 12 consecutive years, with $8.3 million as the latest value for Q1 2026.

  • For Q1 2026, Current Leases rose 5.63% year-over-year to $8.3 million; the TTM value through Mar 2026 reached $8.3 million, up 5.63%, while the annual FY2025 figure was $8.4 million, 9.47% up from the prior year.
  • Current Leases hit $8.3 million in Q1 2026 for Wave Life Sciences, roughly flat from $8.4 million in the prior quarter.
  • Across five years, Current Leases topped out at $8.4 million in Q3 2025 and bottomed at $4.4 million in Q2 2022.
  • Average Current Leases over 5 years is $6.8 million, with a median of $6.9 million recorded in 2024.
  • Year-over-year, Current Leases soared 44.05% in 2023 and then increased 5.63% in 2026.
  • Wave Life Sciences' Current Leases stood at $5.5 million in 2022, then grew by 22.16% to $6.7 million in 2023, then increased by 13.76% to $7.6 million in 2024, then grew by 9.47% to $8.4 million in 2025, then fell by 0.39% to $8.3 million in 2026.
  • According to Business Quant data, Current Leases over the past three periods came in at $8.3 million, $8.4 million, and $8.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.